Select Publications
Book Chapters
2024, 'Clinical/Cardiovascular/Cardiopulmonary Bypass: Effect of Alteration in Pump Speed on Pump Output and Left Ventricular Filling with Continuous-Flow Left Ventricular Assist Device', in American Society for Artificial Internal Organs (ASAIO) Platinum 70th Anniversary Special Edition, CRC Press, pp. 238 - 242, http://dx.doi.org/10.1201/9781003543480-37
,Journal articles
2024, 'Pulsatile Vascular Afterload Measurement Improves Prediction of Right-Sided Heart Dysfunction in Undifferentiated and Left-Sided Pulmonary Hypertension', Journal of the American Heart Association, 13, pp. e034684, http://dx.doi.org/10.1161/JAHA.124.034684
,2024, 'Rapid triage and transition to telehealth for heart transplant patients in the COVID-19 pandemic setting', Journal of Telemedicine and Telecare, 30, pp. 1481 - 1486, http://dx.doi.org/10.1177/1357633X231151714
,2024, 'Cost-Effectiveness of Cardiovascular Magnetic Resonance for Rejection Surveillance After Cardiac Transplantation in the Australian Health Care System', Heart Lung and Circulation, 33, pp. 1173 - 1183, http://dx.doi.org/10.1016/j.hlc.2024.03.004
,2024, 'Cardiac transplantation for transthyretin amyloidosis (ATTR): A single centre experience PB152 (#446)', , http://dx.doi.org/10.26226/m.65f9bf8be6f73964e1d4f5b7
,2024, 'Impact of Left Heart Disease Risk Factors on Outcomes in Pulmonary Arterial Hypertension Therapy', Chest, 165, pp. 967 - 977, http://dx.doi.org/10.1016/j.chest.2023.10.037
,2024, 'Comparative adherence of macitentan versus ambrisentan and bosentan in Australian patients with pulmonary arterial hypertension: a retrospective real-world database study', Journal of Medical Economics, 27, pp. 596 - 604, http://dx.doi.org/10.1080/13696998.2024.2328483
,2024, 'Early Use of Aspirin for Coronary Allograft Prophylaxis in Heart Transplant Recipients', Transplantation, http://dx.doi.org/10.1097/TP.0000000000005131
,2024, 'Effect of sodium glucose cotransporter 2 inhibition immediately prior to heart transplantation', JHLT Open, 5, pp. 100088 - 100088, http://dx.doi.org/10.1016/j.jhlto.2024.100088
,2024, 'Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss in End-Stage Heart Failure Patients Considered for Heart Transplantation', The Journal of Heart and Lung Transplantation, 43, pp. S106 - S106, http://dx.doi.org/10.1016/j.healun.2024.02.213
,2024, 'OPTIMAL MODELLING FOR RIGHT VENTRICULAR AFTERLOAD ASSESSMENT IN PULMONARY HYPERTENSION', Journal of the American College of Cardiology, 83, pp. 2087 - 2087, http://dx.doi.org/10.1016/s0735-1097(24)04077-4
,2024, 'Prognostic Value of Main Pulmonary Artery Diameter in Pulmonary Arterial Hypertension', Heart, Lung and Circulation, 33, pp. S282 - S282, http://dx.doi.org/10.1016/j.hlc.2024.06.337
,2024, 'Safety of Sodium Glucose Co-Transporter 2 Inhibitor Exposure Prior to Heart Transplantation', The Journal of Heart and Lung Transplantation, 43, pp. S148 - S149, http://dx.doi.org/10.1016/j.healun.2024.02.302
,2023, 'SGLT2 Inhibitor-Induced Ketoacidosis in a Patient Without Diabetes', Diabetes Care, 47, pp. e4 - e5, http://dx.doi.org/10.2337/dc23-1903
,2023, 'THU298 Effect Of SGLT2 Inhibition On Metabolic, Cardiac And Renal Outcomes In Heart Transplant Recipients (EMPA-HTx study): Protocol And Study Design', Journal of the Endocrine Society, 7, http://dx.doi.org/10.1210/jendso/bvad114.733
,2023, 'Cardiotoxicity in autologous haematopoietic stem cell transplantation for systemic sclerosis', Journal of Scleroderma and Related Disorders, 8, pp. 87 - 100, http://dx.doi.org/10.1177/23971983221145639
,2023, 'Pre-operative pulmonary artery pulsatility index does not predict mortality post-cardiac transplantation', ESC Heart Failure, 10, pp. 1980 - 1986, http://dx.doi.org/10.1002/ehf2.14226
,2023, 'Prognostic role of pulmonary impedance estimation to predict right ventricular dysfunction in pulmonary hypertension', ESC Heart Failure, 10, pp. 1811 - 1821, http://dx.doi.org/10.1002/ehf2.14180
,2023, 'Tricuspid Regurgitation After Heart Transplantation: The Cause or the Result of Graft Dysfunction?', Transplantation, 107, pp. 1390 - 1397, http://dx.doi.org/10.1097/TP.0000000000004511
,2023, 'Acute Myocarditis and Pericarditis After mRNA COVID-19 Vaccinations—A Single-Centre Retrospective Analysis', Heart Lung and Circulation, 32, pp. 467 - 479, http://dx.doi.org/10.1016/j.hlc.2023.01.002
,2023, 'Characteristic changes to pulsatile and steady-state load according to pulmonary hypertension classification', Physiological Reports, 11, http://dx.doi.org/10.14814/phy2.15662
,2023, 'Sodium glucose co-transporter 2 inhibition with empagliflozin on metabolic, cardiac and renal outcomes in recent cardiac transplant recipients (EMPA-HTx): Protocol for a randomised controlled trial', BMJ Open, 13, http://dx.doi.org/10.1136/bmjopen-2022-069641
,2023, 'Acute Vasoreactivity Testing and Outcomes in Pulmonary Arterial Hypertension: A Call for Increased Testing', Heart Lung and Circulation, 32, pp. 156 - 165, http://dx.doi.org/10.1016/j.hlc.2022.09.005
,2023, 'Heart Transplantation from DCD Donors in Australia: Lessons Learned from the First 74 Cases', Transplantation, 107, pp. 361 - 371, http://dx.doi.org/10.1097/TP.0000000000004294
,2023, '(847) Turning Back The Clock; A Unique Case of Reversible Pulmonary Hypertension', The Journal of Heart and Lung Transplantation, 42, pp. S370 - S370, http://dx.doi.org/10.1016/j.healun.2023.02.860
,2023, 'Acute Myocarditis and Pericarditis After M-RNA COVID-19 Vaccinations—A Single-Centre Retrospective Analysis', Heart, Lung and Circulation, 32, pp. S265 - S265, http://dx.doi.org/10.1016/j.hlc.2023.06.334
,2023, 'Combined Plasmapheresis and Complement Inhibition in a Highly Allosensitised Cardiac Transplant Recipient', Heart, Lung and Circulation, 32, pp. S147 - S148, http://dx.doi.org/10.1016/j.hlc.2023.06.057
,2023, 'Discrepancies in the Clinical and Histopathological Diagnosis of Cardiomyopathy in a Heart Transplant Cohort', Heart, Lung and Circulation, 32, pp. S152 - S152, http://dx.doi.org/10.1016/j.hlc.2023.06.068
,2023, 'Intensive Tacrolimus Level Monitoring After Itraconazole Prophylaxis Cessation Reduces Acute Cellular Rejection Following Heart Transplant', Heart, Lung and Circulation, 32, pp. S164 - S164, http://dx.doi.org/10.1016/j.hlc.2023.06.095
,2023, 'Routine Donor-Specific Antibody Monitoring in Heart Transplant Recipients: Is There a Role?', Heart, Lung and Circulation, 32, pp. S176 - S176, http://dx.doi.org/10.1016/j.hlc.2023.06.122
,2022, 'Pulmonary haemodynamics and pulmonary congestion: where are we now?', European Heart Journal, 43, pp. 4515, http://dx.doi.org/10.1093/eurheartj/ehac499
,2022, 'Efficacy of bortezomib, cyclophosphamide and dexamethasone in cardiac AL amyloidosis', Internal Medicine Journal, 52, pp. 1826 - 1830, http://dx.doi.org/10.1111/imj.15926
,2022, 'Portopulmonary Hypertension: The Interplay Between the Liver and Pulmonary Arteries', Heart Lung and Circulation, 31, pp. 1185 - 1187, http://dx.doi.org/10.1016/j.hlc.2022.07.010
,2022, 'Cardiovascular Magnetic Resonance for Rejection Surveillance After Cardiac Transplantation', Circulation, 145, pp. 1811 - 1824, http://dx.doi.org/10.1161/CIRCULATIONAHA.121.057006
,2022, 'Impact of frailty on mortality and morbidity in bridge to transplant recipients of contemporary durable mechanical circulatory support', Journal of Heart and Lung Transplantation, 41, pp. 829 - 839, http://dx.doi.org/10.1016/j.healun.2022.02.008
,2022, 'Corrigendum: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-Word Prospective Study (Front Pharmacol., (2022), 12, 811700, 10.3389/fphar.2021.811700)', Frontiers in Pharmacology, 13, http://dx.doi.org/10.3389/fphar.2022.891907
,2022, 'The exercise in pulmonary arterial hypertension (ExPAH) study: A randomized controlled pilot of exercise training and multidisciplinary rehabilitation in pulmonary arterial hypertension', Pulmonary Circulation, 12, http://dx.doi.org/10.1002/pul2.12069
,2022, 'The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-word Prospective Study', Frontiers in Pharmacology, 12, http://dx.doi.org/10.3389/fphar.2021.811700
,2022, 'Clinical characteristics and prognosis of cardiac amyloidosis defined by mass spectrometry-based proteomics in an Australian cohort', Internal Medicine Journal, 52, pp. 69 - 78, http://dx.doi.org/10.1111/imj.15072
,2022, 'Validation of Cognitive Impairment in Combination with Physical Frailty as a Predictor of Mortality in Patients with Advanced Heart Failure Referred for Heart Transplantation', Transplantation, 106, pp. 200 - 209, http://dx.doi.org/10.1097/TP.0000000000003669
,2022, 'HIGH OUTPUT HEART FAILURE: A COMPLEX CASE OF AV MALFORMATION AND MULTI-ORGAN FAILURE', Journal of the American College of Cardiology, 79, pp. 2669 - 2669, http://dx.doi.org/10.1016/s0735-1097(22)03660-9
,2022, 'Impact of Initial Therapeutic Strategy on Long-Term Outcomes in Pulmonary Arterial Hypertension: An Analysis of the PHSANZ Registry', Heart, Lung and Circulation, 31, pp. S86 - S86, http://dx.doi.org/10.1016/j.hlc.2022.06.095
,2021, 'Chronic thromboembolic pulmonary hypertension in Australia and New Zealand: An analysis of the PHSANZ registry', Respirology, 26, pp. 1171 - 1180, http://dx.doi.org/10.1111/resp.14162
,2021, 'Impact of left heart disease risk factors on risk stratification and treatment response in pulmonary arterial hypertension', EUROPEAN HEART JOURNAL, 42, pp. 1958 - 1958, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000720456902159&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Waitlist and post-transplant outcomes for eisenmenger syndrome: A comparison of transplant strategies', Journal of Heart and Lung Transplantation, 40, pp. 841 - 849, http://dx.doi.org/10.1016/j.healun.2021.04.005
,2021, 'Everolimus for the Prevention of Calcineurin-Inhibitor-Induced Left Ventricular Hypertrophy After Heart Transplantation (RADTAC Study)', JACC: Heart Failure, 9, pp. 301 - 313, http://dx.doi.org/10.1016/j.jchf.2021.01.007
,2021, 'Pulmonary Vascular Disease as a Systemic and Multisystem Disease', Clinics in Chest Medicine, 42, pp. 167 - 177, http://dx.doi.org/10.1016/j.ccm.2020.11.001
,2021, 'Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry', Respiratory Medicine, 178, http://dx.doi.org/10.1016/j.rmed.2020.106220
,2021, 'The impact of frailty on mortality after heart transplantation', Journal of Heart and Lung Transplantation, 40, pp. 87 - 94, http://dx.doi.org/10.1016/j.healun.2020.11.007
,2020, 'Abstract 14268: Responses to Exercise During Right Heart Catheterisation in Pulmonary Hypertension', Circulation, 142, http://dx.doi.org/10.1161/circ.142.suppl_3.14268
,